000 01615 a2200433 4500
005 20250513191911.0
264 0 _c19991104
008 199911s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.43.9.2302
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBui, K Q
245 0 0 _aMononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cSep 1999
300 _a2302-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcquired Immunodeficiency Syndrome
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAnti-Bacterial Agents
_xblood
650 0 4 _aArea Under Curve
650 0 4 _aAzithromycin
_xblood
650 0 4 _aClarithromycin
_xblood
650 0 4 _aCross-Over Studies
650 0 4 _aFemale
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aLeukocytes, Mononuclear
_xmetabolism
650 0 4 _aMale
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aMycobacterium avium Complex
_xdrug effects
650 0 4 _aMycobacterium avium-intracellulare Infection
_xprevention & control
650 0 4 _aNeutrophils
_xmetabolism
700 1 _aMcNabb, J
700 1 _aLi, C
700 1 _aNightingale, C H
700 1 _aNicolau, D P
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 43
_gno. 9
_gp. 2302-4
856 4 0 _uhttps://doi.org/10.1128/AAC.43.9.2302
_zAvailable from publisher's website
999 _c10429087
_d10429087